Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Vanderson Galan"'
Autor:
Sarah Moherdaui Martins, Vinicius Müller, Vanderson Galan, Fabio Pinheiro de Souza, Itamar Francisco Andreazza, Maurício Ferreira da Rosa
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 54, Iss 4 (2019)
Multiparticulate systems have biopharmaceutical advantages when compared to the monolithic systems, once they allow different patterns of drug release and can be used in different treatments. The aim of the present work was to develop a biphasic cont
Externí odkaz:
https://doaj.org/article/be1ebd4ae76c49a6aa1f675df0478667
Autor:
Sarah Moherdaui Martins, Mauricio Ferreira da Rosa, Fábio Souza, Vanderson Galan, Vinícius Muller, Itamar Francisco Andreazza
Publikováno v:
Acta Scientiarum: Technology, Vol 40, Iss 1, Pp e30754-e30754 (2018)
Hypertension is one of the most important mortality risks in the world and is considered the leading cause of deaths associated with cardiovascular disease. In an attempt to improve the treatments and apply them to a large number of disorders, a prop
Externí odkaz:
https://doaj.org/article/0d4f23f66be94156a2af0176576e5f40
Autor:
Maurício Ferreira da Rosa, Vinicius Muller, Vanderson Galan, Itamar Francisco Andreazza, Sarah Moherdaui Martins, Fabio Pinheiro de Souza
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Volume: 54, Issue: 4, Article number: e17167, Published: 08 APR 2019
Brazilian Journal of Pharmaceutical Sciences, Vol 54, Iss 4 (2019)
Brazilian Journal of Pharmaceutical Sciences; Vol. 54 No. 4 (2018); e17167
Brazilian Journal of Pharmaceutical Sciences; Vol. 54 Núm. 4 (2018); e17167
Brazilian Journal of Pharmaceutical Sciences; v. 54 n. 4 (2018); e17167
Brazilian Journal of Pharmaceutical Sciences
Universidade de São Paulo (USP)
instacron:USP
Brazilian Journal of Pharmaceutical Sciences, Vol 54, Iss 4 (2019)
Brazilian Journal of Pharmaceutical Sciences; Vol. 54 No. 4 (2018); e17167
Brazilian Journal of Pharmaceutical Sciences; Vol. 54 Núm. 4 (2018); e17167
Brazilian Journal of Pharmaceutical Sciences; v. 54 n. 4 (2018); e17167
Brazilian Journal of Pharmaceutical Sciences
Universidade de São Paulo (USP)
instacron:USP
Multiparticulate systems have biopharmaceutical advantages when compared to the monolithic systems, once they allow different patterns of drug release and can be used in different treatments. The aim of the present work was to develop a biphasic cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c940959220b4b102d5d0d2d29cd92f2
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502018000400607&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502018000400607&lng=en&tlng=en